GFAP, NfL, pTau-181, Aβ40, and Aβ42 are shown to be significantly associated with AD brain and cognitive alterations, as well as having good predictive value for identifying people at risk of cognitive impairment and AD prior to clinical symptoms [25–29]. This evidence concerns the gene NEFL and Cognitive impairment.